Induction of Apoptosis in Small-Cell Lung Cancer Cells by an Antisense Oligodeoxynucleotide Targeting the Bcl-2 Coding Sequence

Molecular Cloning: A Laboratory Manual

2001 • 133,517 citations

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1987 • 64,270 citations

Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction

1987 • 45,673 citations

Cancer: Principles and Practice of Oncology.

1991 • 8,402 citations

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

1991 • 4,682 citations

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

1990 • 3,817 citations

Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probes

1980 • 1,884 citations

Use of an Aqueous Soluble Tetrazolium/Formazan Assay for Cell Growth Assays in Culture

1991 • 1,459 citations

p53: A Frequent Target for Genetic Abnormalities in Lung Cancer

1989 • 1,214 citations

Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation.

1993 • 1,144 citations

Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.

1986 • 1,118 citations

The molecular biology of apoptosis.

1996 • 963 citations

BCL-2 antisense therapy in patients with non-Hodgkin lymphoma

1997 • 502 citations

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase

1996 • 444 citations

Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.

1994 • 280 citations

Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation

1993 • 275 citations

Bcl-2 expression prevents activation of the ICE protease cascade.

1996 • 254 citations

Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis.

1992 • 250 citations

Implication of RNA structure on antisense oligonucleotide hybridization kinetics

1992 • 223 citations

Expression of bcl-2 in small cell lung carcinoma cells.

1994 • 222 citations

Diminished Cell Proliferation Associated with the Death-protective Activity of Bcl-2

1996 • 202 citations

Reversal of Chemoresistance of Lymphoma Cells by Antisense-Mediated Reduction ofbcl-2 Gene Expression

1994 • 190 citations

Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model.

1994 • 187 citations

Apoptosis of Lung Cancer Cells Caused by Some Anti-cancer Agents (MMC, CPT-11, ADM) is Inhibited by BCL-2

1993 • 168 citations

Expression of bcl‐2 oncogene protein is prevalent in small cell lung carcinomas

1995 • 167 citations

Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines

1994 • 153 citations

Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.

1993 • 144 citations

Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells.

1989 • 138 citations

The state of the art in antisense research

1995 • 132 citations

Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C.

1995 • 122 citations

Inhibition of rabbit globin mRNA translation by sequence-specific oligodeoxyribonucleotides

1985 • 115 citations

Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues

1993 • 107 citations

Detection of bcl-2 protein and bcl-2 messenger RNA in normal and neoplastic lymphoid tissues by immunohistochemistry and in situ hybridization

1992 • 104 citations

Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K

2008 • 97 citations

Investigations of Antisense Oligonucleotides Targeted Againstbcl-2RNAs

1993 • 95 citations

Walking along human c-myc mRNA with antisense oligodeoxynucleotides: maximum efficacy at the 5' cap region.

1991 • 89 citations

A cis-acting element in the BCL-2 gene controls expression through translational mechanisms.

1996 • 85 citations

Target dependence of antisense oligodeoxynucleotide inhibition of c-Ha-ras p21 expression and focus formation in T24-transformed NIH3T3 cells.

1990 • 55 citations

Antisense oligodeoxyribonucleotide down-regulation of bcl-2 gene expression inhibits growth of the low-grade non-Hodgkin's lymphoma cell line WSU-FSCCL.

1995 • 45 citations

Mechanisms of drug resistance in human lung cancer cells.

1993 • 42 citations